UF startup Cannabix Technologies Inc., the developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, provides the following statement related to the government of Canada’s authorization of roadside saliva-testing devices under bill C-46:
“It has been well signaled for some time by the Canadian government that a roadside saliva-testing device would be used when Canada legalizes marijuana later this year. The move to use saliva testing, we believe, is because no court-accepted breath test device currently exists on the market. This is the chief objective of Cannabix and our ongoing advanced product development work. Saliva testing is not a new technology and has been available for many years. There are well-documented issues with saliva testing including its ability to effectively identify impaired individuals and operate in cold weather conditions, to name a few.
“Of note, the Vermont Senate Judiciary Committee recently rejected a bill authorizing the use of saliva testing in traffic enforcement, amid concerns of scientific validity, accuracy, and infringement on civil liberties. Cannabix believes that an accurate breath test for THC is the future for law enforcement and workplace testing, as it is less invasive and will look to provide superior sensitivity to better determine impairment. The Company has received significant interest for its technology from police and companies in the U.S., Canada and elsewhere. As the issue of drugged driving becomes increasingly acute, Cannabix is committed to using its technology, R&D and scientific experience to provide effective tools to aid law enforcement and help governments and the public transition to marijuana legalization in various jurisdictions. Cannabix is a well-funded Canadian company that is rapidly developing a FAIMS-based marijuana breathalyzer.”